Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 38, 2011, Pages 15972-15977

  Cho, Sung Hoon ^a   Ahn, Annie K ^a   Bhargava, Prerna ^b   Lee, Chih Hao ^b   Eischen, Christine M ^a   McGuinness, Owen ^a   Boothby, Mark ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL MATURATION; CYTOKINE RELEASE; ENZYME ACTIVITY; GLYCOLYSIS; LYMPHANGIOGENESIS; LYMPHOMA; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; GLUCOSE; GLYCOLYSIS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; INTERLEUKIN-4; LYMPHOMA; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; STAT6 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS;

MAMMALIA;

EID: 80053158632     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017082108     Document Type: Article

References (46)

1. Plas DR, Rathmell JC, Thompson CB (2002) Homeostatic control of lymphocyte survival: Potential origins and implications. Nat Immunol 3:515-521. (Pubitemid 34662302)
2. Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA, Thompson CB (2000) In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell 6:683-692.
3. Fox CJ, Hammerman PS, Thompson CB (2005) Fuel feeds function: Energy metabolism and the T-cell response. Nat Rev Immunol 5:844-852. (Pubitemid 41581666)
4. Lum JJ, et al. (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120:237-248. (Pubitemid 40174766)
5. Boothby M, Mora AL, Stephenson LM (2001) Lymphokine-dependent proliferation of T-lymphoid cells: Regulated responsiveness and role in vivo. Crit Rev Immunol 21:487-522. (Pubitemid 34579089)
6. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 17:701-738. (Pubitemid 29241138)
7. Wofford JA, Wieman HL, Jacobs SR, Zhao Y, Rathmell JC (2008) IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 111:2101-2111. (Pubitemid 351451522)
8. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: Metabolism and tumor cell growth. Curr Opin Genet Dev 18:54-61. (Pubitemid 351694453)
9. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13:472-482. (Pubitemid 351766797)
10. Osborne LC, Duthie KA, Seo JH, Gascoyne RD, Abraham N (2010) Selective ablation of the YxxM motif of IL-7Rα suppresses lymphomagenesis but maintains lymphocyte development. Oncogene 29:3854-3864.
11. Bruns HA, Kaplan MH (2006) The role of constitutively active Stat6 in leukemia and lymphoma. Crit Rev Oncol Hematol 57:245-253. (Pubitemid 43239604)
12. Leonard WJ, O'Shea JJ (1998) Jaks and STATs: Biological implications. Annu Rev Immunol 16:293-322. (Pubitemid 28183367)
13. Goenka S, Boothby M (2006) Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proc Natl Acad Sci USA 103:4210-4215.
14. Goenka S, Cho SH, Boothby M (2007) Collaborator of Stat6 (CoaSt6)-associated poly (ADP-ribose) polymerase activity modulates Stat6-dependent gene transcription. J Biol Chem 282:18732-18739. (Pubitemid 47100134)
15. Cho SH, et al. (2009) PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. Blood 113:2416-2425.
16. Yanagawa T, et al. (2007) Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14. Cancer Res 67:8682-8689. (Pubitemid 47437443)
17. Aguiar RC, et al. (2000) BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood 96:4328-4334.
18. Hardie DG (2007) AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774-785.
19. Wurster AL, Rodgers VL, White MF, Rothstein TL, Grusby MJ (2002) Interleukin-4- mediated protection of primary B cells from apoptosis through Stat6-dependent upregulation of Bcl-xL. J Biol Chem 277:27169-27175. (Pubitemid 34951732)
20. Dufort FJ, et al. (2007) Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol 179:4953-4957.
21. Manning BD, Cantley LC (2007) AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274. (Pubitemid 46962095)
22. Majewski N, et al. (2004) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16:819-830. (Pubitemid 39586539)
23. Gottlob K, et al. (2001) Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-1418. (Pubitemid 32524647)
24. Rabin EM, Ohara J, Paul WE (1985) B-cell stimulatory factor 1 activates resting B cells. Proc Natl Acad Sci USA 82:2935-2939. (Pubitemid 15097767)
25. Patke A, Mecklenbräuker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A (2006) BAFF controls B cell metabolic fitness through a PKC β- and Akt-dependent mechanism. J Exp Med 203:2551-2562. (Pubitemid 44664624)
26. Vaux DL, Cory S, Adams JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
27. Langdon WY, Harris AW, Cory S, Adams JM (1986) The c-myc oncogene perturbs B lymphocyte development in E-μ-myc transgenic mice. Cell 47:11-18. (Pubitemid 17181528)
28. Iritani BM, Eisenman RN (1999) c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci USA 96:13180-13185.
29. Kleine H, et al. (2008) Substrate-assisted catalysis by PARP10 limits its activity to mono- ADP-ribosylation. Mol Cell 32:57-69.
30. Hassa PO, Haenni SS, Elser M, Hottiger MO (2006) Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol Mol Biol Rev 70:789-829. (Pubitemid 44484693)
31. Krishnakumar R, Kraus WL (2010) The PARP side of the nucleus: Molecular actions, physiological outcomes, and clinical targets. Mol Cell 39:8-24.
32. Karras GI, et al. (2005) The macro domain is an ADP-ribose binding module. EMBO J 24:1911-1920. (Pubitemid 40896163)
33. Dani N, et al. (2009) Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome. Proc Natl Acad Sci USA 106:4243-4248.
34. Abraham N, et al. (2005) Haploinsufficiency identifies STAT5 as a modifier of IL-7- induced lymphomas. Oncogene 24:5252-5257. (Pubitemid 41192442)
35. Kim JW, et al. (2004) Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol 24:5923-5936.
36. Eischen CM, Woo D, Roussel MF, Cleveland JL (2001) Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol 21:5063-5070. (Pubitemid 32656403)
37. Jalving M, et al. (2010) Metformin: Taking away the candy for cancer? Eur J Cancer 46: 2369-2380.
38. Wang Y, et al. (2009) AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation 119:835-844.
39. Culmsee C, Monnig J, Kemp BE, Mattson MP (2001) AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17:45-58. (Pubitemid 32928285)
40. Campàs C, et al. (2003) Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 101:3674-3680. (Pubitemid 36857958)
41. Kefas BA, et al. (2003) AICA-riboside induces apoptosis of pancreatic β cells through stimulation of AMP-activated protein kinase. Diabetologia 46:250-254. (Pubitemid 36343889)
42. Inoki K, Zhu T, Guan KL (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577-590. (Pubitemid 37506046)
43. De Alboran IM, et al. (2001) Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14:45-55. (Pubitemid 32144686)
44. Miller JP, Yeh N, Vidal A, Koff A (2007) Interweaving the cell cycle machinery with cell differentiation. Cell Cycle 6:2932-2938.
45. Kojima H, et al. (2010) Differentiation stage-specific requirement in hypoxia-inducible factor-1α-regulated glycolytic pathway during murine B cell development in bone marrow. J Immunol 184:154-163.
46. Otsu M, et al. (2002) Reconstitution of lymphoid development and function in ZAP-70-deficient mice following gene transfer into bone marrow cells. Blood 100:1248-1256. (Pubitemid 34864279)